Early tacrolimus exposure does not impact long-term outcomes after liver transplantation
Mikel Gastaca, Patricia Ruiz, Alberto Ventoso, Ibone Palomares, Mikel Prieto, Andres Valdivieso, Department of HPB Surgery and Liver Transplantation Unit, Hospital Universitario Cruces, Bilbao 48903, Spain
Javier Bustamante, José Ramón Fernandez, Milagros Testillano, Patricia Salvador, Maria Senosiain, Maria Jesus Suárez, Department of Hepatology Unit, Hospital Universitario Cruces, Bilbao 48903, Spain
Lorea Martinez-Indart, Department of Bioinformatics and Statistics Platform, Biocruces Bizkaia Health Research Institute, Hospital Universitario Cruces, Bilbao 48903, Spain
Author contributions: Gastaca M designed and performed the research and wrote the paper; Ruiz P and Bustamante J designed the research and supervised the report; Martinez-Indart L provided the statistical analysis; Ventoso A, Palomares I, Prieto M, Salvador P, and Senosiain M acquired and analyzed the data; Testillano M, and Suárez MJ and Valdivieso A supervised the report; all authors approved the final version of the article.
Institutional review board statement: This study was reviewed and approved by the Research Ethics Committee of the Hospital Universitario Cruces, No. CEIC E13/08.
Informed consent statement: Patients gave written consent to be included in the liver transplantation prospective data base. The requirement for specific informed consent for this study was waived because of the retrospective nature of the study.
Conflict-of-interest statement: MG is a member of advisory boards and has received honoraria from Astellas, Novartis and Chiesi. JB has received honoraria from Astellas and Novartis. AV has received honoraria from Astellas and Novartis. All other authors have no conflicts to declare.
Data sharing statement: No additional data are available.
: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Mikel Gastaca, MD, Associate Professor, Surgeon, Department of HPB Surgery and Liver Transplantation Unit, Hospital Universitario Cruces, PLaza de Cruces s/n, Bilbao 48903, Spain. firstname.lastname@example.org
Received: August 14, 2020
Peer-review started: August 14, 2020
First decision: December 11, 2020
Revised: December 27, 2020
Accepted: March 12, 2021
Article in press: March 12, 2021
Published online: March 27, 2021